Literature DB >> 19116753

Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.

Umit Aydogmus1, Servet Ozdemir, Levent Cansever, Yasar Sonmezoglu, Celalettin Ibrahim Kocaturk, Mehmet Ali Bedirhan.   

Abstract

INTRODUCTION: To determine the factors affecting the success of bedside talc slurry (TS) used for symptomatic treatment of patients with malignant pleural effusion (MPE).
METHODS: Data of 113 effusions in 103 MPE patients treated between 1999 and 2007 were retrospectively evaluated for the study. The study group involved 73 patients whose follow-up information was available out of 81 patients treated by TS. Causes of MPE were lung cancer in 22 patients (30.1%) and breast carcinoma in 21 patients (28.8%).
RESULTS: The success rate of TS was significantly higher if the time period between radiological diagnosis of effusion and administration of TS was less than 30 days (P= .02), or spontaneous expansion was attained after chest tube drainage (CTD) (P= .01). Success rate was higher for patients with daily drainage of less than 200 ml before TS than patients with more than 200 ml of daily drainage (P= .01). Dose of talc, either 4 g or above (P= .34), primary cause of MPE (P= .53), time to termination of CTD (P= .57), amount of drainage when CTD was terminated (P= .23), and time period between CTD and administration of TS (P= .20) did not show a statistically significant effect on the success of TS.
CONCLUSION: In the treatment of malignant pleural effusion, patients with daily drainage of less than 200 ml before TS developed less recurrence than patients with daily drainage of more than 200 ml. Longer time period between the diagnosis of MPE and onset of CTD increased recurrence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116753     DOI: 10.1245/s10434-008-0263-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  A pilot study-is there a role for mitoxantrone pleurodesis in the management of pleural effusion due to lung cancer?

Authors:  Katherina-Bernadette Sreter; Marko Jakopovic; Zoran Janevski; Miroslav Samarzija; Paul Zarogoulidis; Ioannis Kioumis; Nikolaos Mparmpetakis; Athanasia Pataka; Konstantinos Zarogoulidis; Theodora Tsiouda; Christoforos Kosmidis; Sofia Mpaka; Haidong Huang; Wolfgang Hohenforst-Schmidt; Charalampos Charalampidis; Nikolaos Machairiotis; Bojan Zaric; Aleksandar Milovancev
Journal:  Ann Transl Med       Date:  2016-05

2.  Prolonged pleural catheters in the management of pleural effusions due to breast cancer.

Authors:  Ozkan Demirhan; Cetin Ordu; Alper Toker
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

3.  Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases.

Authors:  Nobuaki Matsubara; Kuniaki Itoh; Hirofumi Mukai; Shunji Nagai
Journal:  Int J Clin Oncol       Date:  2011-10-07       Impact factor: 3.402

4.  Tumor type influences the effectiveness of pleurodesis in malignant effusions.

Authors:  Silvia Bielsa; Paula Hernández; Francisco Rodriguez-Panadero; Teresa Taberner; Antonieta Salud; José M Porcel
Journal:  Lung       Date:  2011-02-18       Impact factor: 2.584

5.  Treatment of malignant pleural effusion: a cost-effectiveness analysis.

Authors:  Varun Puri; Tanya L Pyrdeck; Traves D Crabtree; Daniel Kreisel; Alexander S Krupnick; Graham A Colditz; G Alexander Patterson; Bryan F Meyers
Journal:  Ann Thorac Surg       Date:  2012-05-10       Impact factor: 4.330

6.  The effect of silver nitrate pleurodesis after a failed thoracoscopic talc poudrage.

Authors:  Cecilia Menna; Claudio Andreetti; Mohsen Ibrahim; Giulio Maurizi; Camilla Poggi; Rocco Barile; Francesco Cassiano; Erino A Rendina
Journal:  Biomed Res Int       Date:  2013-09-01       Impact factor: 3.411

7.  Malignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy.

Authors:  Tsuyoshi Shinohara; Hiroyuki Yamada; Yoshiro Fujimori; Kiyofumi Yamagishi
Journal:  Am J Case Rep       Date:  2013-06-03

8.  A multidirectional two-tube method for chemical pleurodesis could improve distribution of the sclerosing agent within the pleural cavity - A pilot study.

Authors:  Eoin Campion; Saad I Mallah; Maimoona Azhar; Dara O'Keeffe; Aamir Hameed
Journal:  Ann Med Surg (Lond)       Date:  2021-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.